Newsbenzinga
Teva Pharmaceuticals Receives FDA Approval Of WELTRUZA For Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…